MEDTRONIC, INC. : Correction to Medtronic Earnings Story
05/21/2013| 09:01am US/Eastern
"Medtronic 4th-Quarter Net Falls 2.2% on Charges; Revenue Up," at 7:47 a.m. EDT, misstated the segment-sales results in the sixth and seventh paragraphs. Sales from the cardiac rhythm disease management segment rose 2.9% to $1.33 billion, not fell 4.8% to $1.19 billion. Overall defibrillators revenue increased 1.5%, not decreased 3.2%, and pacemaker sales were up 2.6%, not down 8.9%. Spinal-products sales declined 0.9% to $811 million, not 4.7% to $786 million.